With safety and efficacy data, Covaxin will be available in the first quarter of 2020, he said. (Archive)
Hyderabad:
Covaxin, a vaccine for COVID-19, will be available in the first quarter of next year, said Suchitra Ella, joint managing director of Bharat Biotech on Wednesday.
“With the safety and efficacy data, Covaxin will be available in the first quarter of next year for the categories and first responders according to the plan that the Government of India is undertaking for phased vaccination,” said Ms. . She.
A team of foreign mission chiefs in India had visited leading biotech companies in Hyderabad involved in the development of the COVID-19 vaccine.
The Indian branch of the US pharmaceutical giant Pfizer, the Pune-based Serum Institute of India (SII) and Hyderabad-based Bharat Biotech have submitted an application to the Comptroller General of Drugs of India (DCGI) seeking a use authorization. (USA) for your COVID-19. vaccinations
Meanwhile, the Subject Matter Expert Committee (SEC) of the Comptroller General of Medicines of India (DCGI) has requested more safety and efficacy data from the Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines.
.
